# FDA Inspection 1060251 - Southwest Transplant Alliance - June 21, 2018

Source: https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance/c27a4bdc-e130-4b3a-a62e-27a928919d5f
Source feed: FDA_Inspections

> FDA Inspection 1060251 for Southwest Transplant Alliance on June 21, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1060251
- Company Name: Southwest Transplant Alliance
- Inspection Date: 2018-06-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217077 - 2023-08-22](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance/a5b34903-f0f8-4b87-b362-77632ca4c1dd)
- [FDA Inspection 1060251 - 2018-06-21](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance/ba004dff-fcfa-401d-8344-06cb6b81f961)

Company: https://www.keypedia.com/companies/southwest-transplant-alliance/43f2ffd4-0dda-4807-bbcc-8acfd3c8cdcf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d